Introduction of Allogeneic Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7
introduction of allogeneic engineered chimeric antigen receptor t-cell immunotherapy into central vein, percutaneous approach, new technology group 7
Introduction of Allogeneic Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7
introduction of allogeneic engineered chimeric antigen receptor t-cell immunotherapy into central vein, percutaneous approach, new technology group 7